ncRNA name
FER1L4
Specific or universal ncRNAs
Specific ncRNAs
Class
Long noncoding RNA
Biomarker
None
Biomarker application
Upstream regulatory factors
Not available
Downstream target
miR-106a-5p/miR-372-5p/E2F1
Cancer name
Liver Cancer
Cancer site
qRT-PCR,Western blot,Dual-luciferase assay
Treatment type
Chemotherapy
Drug
None
Impact of wild-type ncRNA on chemotherapy resistance
Up
Impact of knockdown of ncRNA on chemotherapy resistance
Impact of overexpression of ncRNA on chemotherapy resistance
ncRNA differential expression in
cancer
patients vs. healthy people
Not available
Number of patients
Not available
Male patients
Not available
Female patients
Not available
Age range and number
Not available
PMID
Description
the results indicated that FER1L4 could inhibit the expression of miR-106a-5p/miR-372-5p, to activate E2F1-mediated NF-ĪŗB pathway, leading to drug resistance in liver cancer
Tissue resource
tissues from patients with liver cancer
Liver cell line THLE-3
liver cancer cell lines SK-HEP-1
liver cancer cell lines HEP3B
liver cancer cell lines HUH-7
Experiment
None
Institute
Sichuan Provincial People’s Hospital
the Cell Bank at the Chinese Academy of Sciences
Country
China
China
Continent
Asia
Asia